Log in to save to my catalogue

Identification and clinical validation of NUSAP1 as a novel prognostic biomarker in ovarian cancer

Identification and clinical validation of NUSAP1 as a novel prognostic biomarker in ovarian cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_dc22067d973d496f91024224b8397803

Identification and clinical validation of NUSAP1 as a novel prognostic biomarker in ovarian cancer

About this item

Full title

Identification and clinical validation of NUSAP1 as a novel prognostic biomarker in ovarian cancer

Publisher

London: BioMed Central Ltd

Journal title

BMC cancer, 2022-06, Vol.22 (1), p.1-690, Article 690

Language

English

Formats

Publication information

Publisher

London: BioMed Central Ltd

More information

Scope and Contents

Contents

Background Nucleolar and spindle-associated protein 1 (NUSAP1) was shown to be involved in cell cycle regulation in cancer. However, its prognostic value and underlying mechanism in ovarian cancer remain unclear. Methods Oncomine, TCGA, CCLE, and UALCAN databases were used to analyze the expression level of NUSAP1 in ovarian cancer. The Kaplan-Meie...

Alternative Titles

Full title

Identification and clinical validation of NUSAP1 as a novel prognostic biomarker in ovarian cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_dc22067d973d496f91024224b8397803

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_dc22067d973d496f91024224b8397803

Other Identifiers

ISSN

1471-2407

E-ISSN

1471-2407

DOI

10.1186/s12885-022-09753-4

How to access this item